Search Results for the EPA National Library Catalog

Items Found: 75

Showing: Items 1 - 50

Your Search: (SUBJECT=Drug industry)

 
 
 

1 2 NEXT
Select Item Title Year Published
Amendment to the best demonstrated available technology (BDAT) background document for F006 / 1988
American pharmaceutical review. 1998
Analysis of costs for compliance with federal radiation protection guidance for occupational exposure (proposed on January 23, 1981). Volume II, Case study analysis of the impacts of proposed radiation protection guidance for workers / 1983
Analytical methods for the determination of pollutants in pharmaceutical manufacturing industry wastewater. 1995
Analytical methods for the determination of pollutants in pharmaceutical manufacturing industry wastewater. 1995
Biological Products. Establishments Licensed for the Preparation and Sale of Viruses, Serums, Toxins and Analogous Products, and the Trivalent Organic Arsenic Compounds. 1969
Characteristics of wastewaters from ethical pharmaceutical industry. 1974
Chemical technology and economics in environmental perspectives. Task IV Activated carbon. 1977
Compliance Evaluation Inspection Report: Center Laboratories, Port Washington, New York. 1992
Cost-effectiveness analysis of proposed effluent limitations guidelines for the pharmaceutical manufacturing industry : final report. 1995
Cost-effectiveness analysis of proposed effluent limitations guidelines for the pharmaceutical manufacturing industry [Microfiche] : final report. 1995
Deep Wells for Industrial Waste Injection in the United States. Summary of Data. 1967
Development document for effluent guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category / 1982
Development document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing point source category. 1998
Development document for final effluent limitations guidelines, new source performance standards, and pretreatment standards for the pharmaceutical manufacturing point source category. 1983
Development document for interim final effluent limitations guidelines and proposed new source performance standards for the pharmaceutical manufacturing point source category. 1976
Development document for interim final effluent limitations guidelines and proposed new source performance standards for the pharmaceutical manufacturing point source category. 1976
Development document for proposed effluent limitations guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category. 1982
Development of a Baseline for Use in Assessing Impacts of the Toxic Substances Control Act (TSCA) on the Chemicals Industry. 1982
Drug repositioning : bringing new life to shelved assets and existing drugs / 2012
Drug truths : dispelling the myths about pharma R & D / 2009
Drugs and the environment : stewardship & sustainability / 2010
Economic analysis of effluent standards and limitations for the pharmaceutical industry / 1983
Economic analysis of final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry. 1998
Economic impact and regulatory flexibility analysis of proposed effluent guidelines for the pharmaceutical manufacturing industry : final report. 1995
Economic impact and regulatory flexibility analysis of proposed effluent guidelines for the pharmaceutical manufacturing industry [Microfiche] : final report. 1995
Economic Impact of Implementing Volatile Organic Compound Group II Regulations in Ohio 1981
Economic impact of implementing volatile organic compound group II regulations in Ohio / 1981
Enforceability Aspects for RACT (Reasonably Available Control Technology) for the Chemical Synthesis Pharmaceutical Industry. 1981
Environmental Assessment and Overview of Biotechnology Process Applications. 1984
Environmental assessment of the proposed effluent guidelines for the pharmaceutical manufacturing industry. 1995
EPA Office of Compliance Sector Notebook Project. Profile of the pharmaceutical manufacturing industry. 1997
Evaluation of biological treatment of pharmaceutical wastewater with PAC addition / 1988
Evaluation of biological treatment of pharmaceutical wastewater with PAC addition {microform}, volume 2. Appendices / 1988
From bench to pilot plant : process research in the pharmaceutical industry / 2002
Guidelines for the cleanup of clandestine drug laboratories / 1990
Health services industry detailed study : management and disposal of unused pharmaceuticals / 2008
Industrial Solid Waste Classification Systems. 1975
Joint federal task force on clandestine (illegal) drug laboratories {microfiche}. 1990
Literature Search and Critical Analysis of Biological Trickling Filter Studies - Volume I. 1971
Materials balance and technology assessment of mercury and its compounds on national and regional bases. 1975
Monetizing the Pharmacological Benefits of Plants. 1991
National air pollutant emission trends procedures document 1900-1993. 1994
National Emission Standards for Hazardous Air Pollutants (NESHAP) Manufacturing Industry: Summary of Publice Comments and Responses. 1998
National profile : chemicals management in Germany / 2000
New Approach for Water Reclamation--Complete Treatment of Waste Water by Physico-Chemical Processes. 1972
Pharmaceutical industry : hazardous waste generation, treatment, and disposal. 1976
Pharmaceutical Manufacturing Industry Effluent Limitations Guidelines and Standards Public Meeting. Held on May 23, 1994. 1994
Pollution control in the organic chemical industry / 1974
Pollution prevention assessment for a manufacturer of pharmaceuticals / 1995
1 2 NEXT

Save, Print or Email Selected Records